FDA / 2019
FDA highlights concerns with glutathione in compounded sterile injectables
FDA highlights concerns with glutathione in compounded sterile injectables — U.S. FDA (2019), cited in PeptideAgent's Glutathione evidence record.
Open original sourceSOURCE METADATA
What this record represents.
- Publisher
- U.S. FDA
- Evidence type
- FDA
- Publication year
- 2019
- Source ID
- fda-glutathione-alert
WHERE THIS IS CITED